Casi Pharmaceuticals Inc (CASI)
1.85 x 1 3.52 x 2
Pre-market by (Cboe BZX)
2.20 +0.09 (+4.27%) 03/27/25 [NASDAQ]
1.85 x 1 3.52 x 2
Pre-market 2.20 unch (unch) 16:00 ET
for Thu, Mar 27th, 2025
Fiscal Year End Date: 12/31
12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
Cash Flows From Operating Activities | |||||
Net Income | -19,494 | -39,022 | -43,309 | -48,794 | -36,886 |
Depreciation Amortization | 1,137 | 1,509 | 1,376 | 1,078 | 902 |
Accounts receivable | -210 | -132 | 1,296 | -855 | -506 |
Accounts payable and accrued liabilities | -4,684 | -5,785 | 7,747 | 3,675 | 2,795 |
Other Working Capital | -6,133 | -5,411 | 9,352 | 2,737 | -47 |
Other Operating Activity | 5,078 | 3,307 | -29,335 | -2,087 | -2,052 |
Operating Cash Flow | $-24,306 | $-45,535 | $-52,874 | $-44,247 | $-35,795 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -2,336 | N/A | N/A | N/A | 4,352 |
PPE Investments | -33 | 2,382 | -986 | -1,640 | -1,937 |
Sale Of Investment | -418 | N/A | 22,410 | N/A | N/A |
Investing Cash Flow | $-2,786 | $2,382 | $21,424 | $-1,640 | $2,416 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | 2,261 | 2,190 | N/A | 3,000 |
Debt Repayment | -92 | -1,006 | -997 | -1,118 | -95 |
Common Stock Issued | 37,929 | 10,173 | 47,139 | 49,316 | 29,516 |
Common Stock Repurchased | N/A | N/A | N/A | -3,833 | -3,833 |
Other Financing Activity | 0 | 14,405 | 0 | 0 | 0 |
Financing Cash Flow | $37,837 | $25,833 | $48,332 | $44,364 | $28,588 |
Beginning Cash Position | 24,067 | 41,386 | 24,504 | 26,027 | 30,819 |
End Cash Position | 34,812 | 24,067 | 41,386 | 24,504 | 26,027 |
Net Cash Flow | $10,745 | $-17,319 | $16,882 | $-1,523 | $-4,792 |
Free Cash Flow | |||||
Operating Cash Flow | -24,306 | -45,535 | -52,874 | -44,247 | -35,795 |
Capital Expenditure | -33 | -558 | -986 | -1,640 | -1,937 |
Free Cash Flow | -24,339 | -46,093 | -53,860 | -45,888 | -37,732 |